Biotech news
.jpg/r%5Bwidth%5D=1280&r%5Bheight%5D=720/7f40fd90-a367-11f0-96cc-07b8dae1da3b-Untitled%20design%20(1).webp)
Americas
The pharma giant will share rights to new innovations with an AI-driven organoid platform designed to produce fully human antibodies in weeks. 7 October 2025
Americas
From stalled drug approvals to suspended patent investigations, US rightsholders face mounting uncertainty during the federal freeze. 2 October 2025
Americas
Research reveals an increase in global filings in 2024/2025, but concerns remain over the future of vaccine development in the US. 1 October 2025
Americas
The healthtech giant has convinced a US court to freeze the assets of two Chinese startups and their ex-employees for breaching an injunction for trade secret theft of X-ray tubes used in CT scanners. 1 October 2025
Americas
Complaint alleges the pair used Massachusetts company’s patented mRNA TALEN gene-editing technology without permission in multi-billion-dollar cancer therapy deals. 29 September 2025
Europe
The General Court has handed a win to generic drug makers including Teva and Mylan in the battle over multiple sclerosis drug Tecfidera. 25 September 2025
Americas
A biotech firm specialising in mRNA therapies alleges AbbVie’s $2.1 billion Capstan purchase was built on stolen lipid nanoparticle trade secrets. 24 September 2025
Americas
As John Squires is confirmed as the US Patent and Trademark Office's new director, Sarah Speight gathers reaction, and asks: what would you ask the US’ chief IP executive? 23 September 2025
Americas
There are varying national eligibility requirements that distinguish between treatments of and diagnostics for animals and humans; it’s just a question of reformatting ‘method of treatment’ claims, write lawyers from Sterne Kessler. 23 September 2025
Careers
US firm’s new partner “brings a rare combination of scientific depth, global perspective, and strategic legal insight” to her new employer’s life sciences practice. 19 September 2025